Fibromyalgia affects roughly 2% of the global population, making it one of the most common chronic pain conditions worldwide. In the United States, estimates run higher, with prevalence reaching up to 6.4% of adults. That translates to millions of Americans living with widespread pain, fatigue, and other hallmark symptoms.
Global and U.S. Prevalence
A large meta-analysis covering more than 3.6 million people across 65 studies found the overall prevalence of fibromyalgia in the general population to be 1.78%. That number represents a global average, and actual rates vary by country, by the diagnostic criteria used, and by how aggressively clinicians screen for the condition.
In the United States, the estimated prevalence is notably higher, reaching up to 6.4%. The gap likely reflects differences in diagnostic practices and awareness rather than a true difference in how many people experience symptoms. Most of those affected are middle-aged women, a pattern that holds across virtually every population studied.
Who Gets Fibromyalgia
Women are diagnosed with fibromyalgia about four times as often as men. This 4:1 ratio is one of the most consistent findings in the research, though some experts believe men are underdiagnosed because their symptoms may present differently or because they’re less likely to seek care for chronic pain.
The condition peaks in later middle age. In one large study of U.S. veterans, the average age at diagnosis was about 55, though women tended to be diagnosed younger, around age 48, compared to men at roughly 57. More than half of the women in that study were under 49 when diagnosed. Fibromyalgia isn’t limited to adults, either. Estimates put the prevalence in children and adolescents between 1.2% and 6.2%, a range broad enough to suggest many young people with the condition go unrecognized.
Overlap With Other Conditions
Fibromyalgia rates spike dramatically in people who already have certain chronic diseases. Among patients seen in rheumatology clinics, about 15% also meet criteria for fibromyalgia. Around 25% of people with lupus have fibromyalgia as well. The overlap is even more striking in some conditions: studies have found fibromyalgia in nearly 13% of people with irritable bowel syndrome and close to 15% of those with type 2 diabetes.
These overlapping conditions make diagnosis harder, because fibromyalgia symptoms like pain, fatigue, and brain fog can mimic or amplify the symptoms of the underlying disease. A person with lupus, for instance, may assume their widespread pain is a lupus flare when fibromyalgia is actually driving much of their discomfort.
Why the Numbers May Be Underestimated
Fibromyalgia has no blood test, no imaging scan, and no single definitive marker. Diagnosis depends on a clinical evaluation of symptoms, and the criteria for making that diagnosis have changed multiple times over the past three decades. Different versions of the diagnostic criteria can produce different prevalence numbers from the same population, which is one reason estimates range so widely.
The diagnostic journey itself tells the story. On average, people wait 2.3 years from the time they first bring their symptoms to a doctor until they receive a fibromyalgia diagnosis. During that time, the typical patient sees nearly four different physicians. Some are told their symptoms are psychosomatic, others receive incorrect diagnoses, and many cycle through specialists before landing on the right answer. That delay means prevalence figures based on confirmed diagnoses almost certainly undercount the true number of people living with the condition.
Impact on Daily Life and Work
The functional toll of fibromyalgia goes well beyond pain. Studies consistently show that a significant portion of people with the condition struggle to maintain employment. In the United States, about 35% of fibromyalgia patients report work disability. Canadian rates are similar, at around 30%. In Spain, 23% of people with fibromyalgia receive a permanent disability pension because of the condition, with another 11% on sick leave at any given time.
When researchers directly compared people with fibromyalgia to other outpatients, work loss was three times more common in the fibromyalgia group: 46.8% versus 14.1%. Employment rates among people with fibromyalgia vary widely by region, ranging from 34% to 77% across different studies, but the pattern is clear. This is a condition that frequently interferes with the ability to hold a job, maintain a household, and participate in everyday activities.
A community survey of Australians with fibromyalgia found that 35% were receiving financial support related to work disability. These numbers reflect not just pain severity but the combination of fatigue, cognitive difficulties, and sleep disruption that makes sustained concentration and physical effort so challenging for many people with the condition.